Pek 10 vial6 stokJimat 25%PT-141 10 mg
Agonis melanokortin bremelanotide
PT-141 bremelanotide research peptide, Australian-shipped. Lab-verified ≥99% purity.
Untuk tujuan penyelidikan sahaja. Sebatian ini dijual secara ketat untuk penyelidikan in-vitro dan tujuan makmal, dan tidak dimaksudkan untuk kegunaan manusia atau penggunaan terapeutik. Dengan membeli, anda mengesahkan bahawa anda ialah penyelidik yang berkelayakan dan bersetuju dengan penafian penuh kami.
Tinggal 6 pek sahaja
Agonis reseptor melanokortin sintetik yang dikaji untuk kesan terhadap laluan saraf yang dikaitkan dengan tindak balas seksual dalam aplikasi penyelidikan.
PT-141 (bremelanotide) is a synthetic melanocortin-receptor agonist derived from the alpha-melanocyte-stimulating hormone (α-MSH) family. It is one of the most studied melanocortin-pathway research peptides outside of the tanning-active analogues. Quantum Labs supplies PT-141 as a lyophilised powder for Australian research applications.
Research on PT-141 has covered the central melanocortin pathway, particularly MC3R and MC4R receptor activation, and pre-clinical models of sexual-response signalling. Material is HPLC-verified to ≥99% purity and ships from Australian stock; supplied for laboratory research use only.
Mekanisme
Penyelidikan menunjukkan agonisme utama MC4R dengan kesan sistem saraf pusat pada penanda neurokimia pada subjek kajian.
Disahkan HPLC terhadap spesifikasi ketulenan ≥99%. Diuji secara bebas oleh makmal pihak ketiga bertauliah.
PT-141 — soalan lazim
What is PT-141?
PT-141 (bremelanotide) is a synthetic melanocortin-receptor agonist studied in research models of central melanocortin-pathway signalling. It is one of the most-studied research peptides in the melanocortin family alongside the tanning-active analogues.
Is PT-141 legal in Australia?
PT-141 is restricted for compounded human therapeutic supply in Australia and remains available for research and laboratory use when supplied without therapeutic representation. Quantum Labs supplies PT-141 for research use only.
What receptors does PT-141 target?
PT-141 primarily activates the melanocortin-3 (MC3R) and melanocortin-4 (MC4R) receptors. Research has focused on the central melanocortin pathway, particularly downstream signalling in MC4R-rich brain regions.
What is bremelanotide?
Bremelanotide is the generic name for PT-141. It is a cyclic synthetic peptide derived from the α-MSH lineage. PT-141 is the research-code designation; bremelanotide is the pharmaceutical name.
What is the typical PT-141 research dosage?
Published research protocols have used wide dose ranges depending on the model and delivery route (intranasal, subcutaneous). Human dosing is not established. Researchers should consult primary literature for protocol-specific guidance.
Panduan berkaitan PT-141
Penyelidik juga meneliti
Pilihan utamaPek 10 vialJimat 17%HGH
Serbuk liofilisasi10 IU · 4 strengths
Hormon pertumbuhan manusia rekombinan
Dalam 2 gabungan
Pek 10 vialJimat 18%Tesamorelin
Serbuk liofilisasi10 mg · 3 strengths
Analog GHRH yang distabilkan
Dalam 1 gabungan
Pilihan utamaPek 10 vialJimat 22%CJC-1295 + Ipamorelin
Serbuk liofilisasi5 mg + 5 mg
Gabungan klasik GHRH + mimetik ghrelin
Dalam 2 gabungan